Amerise Biosciences Ltd vs Blue Pebble Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Amerise Biosciences Ltd is ₹ 0.82 as of 23 Oct 15:30 . The P/E Ratio of Amerise Biosciences Ltd is 0 as of March 2025 .The P/E Ratio of Blue Pebble Ltd is 14 as of March 2025 . The Market Cap of Amerise Biosciences Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Blue Pebble Ltd is ₹ 70.99 crore as of March 2025 . The Revenue of Amerise Biosciences Ltd is ₹ 0 crore as of Mar '26 .The Revenue of Blue Pebble Ltd is ₹ 11.36 crore as of Mar '26 . The EBITDA of Amerise Biosciences Ltd is ₹ 0 crore as of Mar '26 .The EBITDA of Blue Pebble Ltd is ₹ 0.12 crore as of Mar '26 . The Net Profit of Amerise Biosciences Ltd is ₹ 0 crore as of Mar '26 .The Net Profit of Blue Pebble Ltd is ₹ -0.27 crore as of Mar '26 . The Dividend Payout of Amerise Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Blue Pebble Ltd changed from 4.03 % on March 2025 to 0 % on March 2026 . This represents a CAGR of -100.00% over 2 years .

About Amerise Biosciences Ltd

Amerise Biosciences Limited was initially incorporated as 'Amstar Laminates Limited' in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment.
On October 29, 2002, the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021.
Initially, the Company was engaged into the business of commodity trading. During the financial year 2007 it entered into the trading of castor seeds.
During the year 2024-25, due to financial crisis Company has not carried out any business activities and faces huge set back.

About Blue Pebble Ltd

Blue Pebble Limited was originally incorporated as 'Blue Pebble Private Limited' on September 08, 2017 with the Registrar of Companies, Central Registration Centre.
Company converted into a Public Limited and the name was changed to 'Blue Pebble Limited' vide a fresh certificate of incorporation dated October 25, 2023 issued by the Registrar of Companies, Mumbai. Established in 2017, Blue Pebble specialized in spatial design and offers environmental branding solutions.
The Company provide printing and designing services, including theme-based designs, large format printing, vinyl printing, fabric printing, canvas printing, signage manufacturing, and 3D art installation.
It deal in sourcing and installation of curios, sculpture and artisanal hand paintings.
Through their graphics and signage solutions, Company transform workspace into functional environments that align with clients' corporate culture and values.

FAQs for the comparison of Amerise Biosciences Ltd and Blue Pebble Ltd

Which company has a larger market capitalization, Amerise Biosciences Ltd or Blue Pebble Ltd?

Market cap of Amerise Biosciences Ltd is 5 Cr while Market cap of Blue Pebble Ltd is 24 Cr

What are the key factors driving the stock performance of Amerise Biosciences Ltd and Blue Pebble Ltd?

The stock performance of Amerise Biosciences Ltd and Blue Pebble Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amerise Biosciences Ltd and Blue Pebble Ltd?

As of October 25, 2026, the Amerise Biosciences Ltd stock price is INR ₹0.82. On the other hand, Blue Pebble Ltd stock price is INR ₹59.7.

How do dividend payouts of Amerise Biosciences Ltd and Blue Pebble Ltd compare?

To compare the dividend payouts of Amerise Biosciences Ltd and Blue Pebble Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.